Cluster analyses of the TCGA and a TMA dataset using the coexpression of HSP27 and CRYAB improves alignment with clinical-pathological parameters of breast cancer and suggests different epichaperome influences for each sHSP

Philip R. Quinlan, Grazziela Figeuredo, Nigel Mongan, Lee B. Jordan, Susan E. Bray, Roman Sreseli, Alison Ashfield, Jurgen Mitsch, Paul van den Ijssel, Alastair M. Thompson (Lead / Corresponding author), Roy A. Quinlan (Lead / Corresponding author)

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
9 Downloads (Pure)

Abstract

Our cluster analysis of the Cancer Genome Atlas for co-expression of HSP27 and CRYAB in breast cancer patients identified three patient groups based on their expression level combination (high HSP27 + low CRYAB; low HSP27 + high CRYAB; similar HSP27 + CRYAB). Our analyses also suggest that there is a statistically significant inverse relationship between HSP27 and CRYAB and known clinicopathological markers in breast cancer. Screening an unbiased 248 breast cancer patient tissue microarray (TMA) for the protein expression of HSP27 and phosphorylated HSP27 (HSP27-82pS) with CRYAB also identified three patient groups based on HSP27 and CRYAB expression levels. TMA24 also had recorded clinical-pathological parameters, such as ER and PR receptor status, patient survival, and TP53 mutation status. High HSP27 protein levels were significant with ER and PR expression. HSP27-82pS associated with the best patient survival (Log Rank test). High CRYAB expression in combination with wild-type TP53 was significant for patient survival, but a different patient outcome was observed when mutant TP53 was combined with high CRYAB expression. Our data suggest that HSP27 and CRYAB have different epichaperome influences in breast cancer, but more importantly evidence the value of a cluster analysis that considers their coexpression. Our approach can deliver convergence for archival datasets as well as those from recent treatment and patient cohorts and can align HSP27 and CRYAB expression to important clinical-pathological features of breast cancer.

Original languageEnglish
Pages (from-to)177-188
Number of pages12
JournalCell Stress and Chaperones
Volume27
Early online date2 Mar 2022
DOIs
Publication statusPublished - Mar 2022

Keywords

  • Small heat shock protein
  • HSP27
  • HSPB1
  • Monoclonal antibody specific to phosphorylated Serine 82 in HSP27
  • Alphab-crystallin
  • CryAB
  • HSPB5
  • Breast cancer
  • Cluster analysis
  • Cancer Genome Atlas
  • Epichaperome
  • TP53
  • Estrogen receptor (ER)
  • Progesterone receptor (PR)
  • Patient survival

Fingerprint

Dive into the research topics of 'Cluster analyses of the TCGA and a TMA dataset using the coexpression of HSP27 and CRYAB improves alignment with clinical-pathological parameters of breast cancer and suggests different epichaperome influences for each sHSP'. Together they form a unique fingerprint.

Cite this